Salīdzināt metodes

	Mūža vecumam saistītās makulas deģenerācijas kvalitātes skalas	Impact of Vision Impairment Scale
Nozare	Oftalmoloģija	Oftalmoloģija
Saime	Process / pipeline	Process / pipeline
Izcelsmes gads	2005	2000
Autors	Mitchell J, Bradley C et al.	Wolffsohn JS, Cochrane AL et al.
Tips	Self-report	Self-report
Pirmavots	Mitchell, J., Bradley, C., Anderson, S. J., et al. (2005). Perceived impact of retinal impairment on quality of life: the AMD and Cataract Symptom Effect Questionnaire. Health Qual Life Outcomes, 3(1), 12.	Wolffsohn, J. S., & Cochrane, A. L. (2000). Design of the low vision quality-of-life questionnaire (LVQOL) and measurment of its item and scale validity and reliability. Optometry & Vision Science, 77(3), 144-152.
Citi nosaukumi	AMD-QoL, Macular QoL	IVI, Impact Vision Impairment
Saistītās	4	4
Kopsavilkums	The AMD Quality of Life (AMD-QoL) scale is a disease-specific instrument designed to measure the impact of age-related macular degeneration on patient-reported health-related quality of life. Developed by Mitchell, Bradley, and colleagues (2005), the AMD-QoL addresses concerns unique to macular disease: central vision loss, reading difficulty, facial recognition, driving impairment, and emotional burden. It serves as a primary or secondary outcome in AMD clinical trials and informs patient-centered care decisions.	The Impact of Vision Impairment (IVI) scale is a quality-of-life instrument designed specifically for patients with significant vision loss (low vision) to measure the psychological, functional, and social burden of visual impairment. Developed by Wolffsohn, Cochrane, and colleagues (2000), the IVI captures domains including emotional impact (distress, frustration), functional limitations (mobility, ADLs), social participation, and role fulfillment in populations with moderate to severe vision loss where generic or mild-vision-focused instruments are insensitive.